PMEDFPREDICTMEDIX AI INC.

About PREDICTMEDIX AI INC. (PMEDF)

PREDICTMEDIX AI INC. (PMEDF) is a Medical Devices company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Pink tier.

Predictmedix Inc. is an artificial intelligence ("AI") company developing disruptive and cutting-edge tools for impairment testing and healthcare testing. The Issuer's proprietary technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. The Issuer is also developing cutting edge screening technologies for the healthcare industry. Predictmedix Inc. is expanding its proprietary AI technology to screen for infectious diseases, and also to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer's disease.

Products and services

Predictmedix is a Life Sciences technology company developing AI-powered products to improve workplace health and safety, enhance protection in public environments, and provide tools for medical professionals to better care for patients.

PMEDF key facts

Ticker symbol

PMEDF

Market tier

Pink

Sector

Healthcare

Industry

Medical Devices

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

1987

Employees

20

Estimated market cap

$3.92M (as of Apr 11, 2025)

Shares outstanding

186,534,542

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

1/31

Latest filing

Interim Financial Report (Jul 31, 2024)

PREDICTMEDIX AI INC. leadership

• Sheldon Gary Kales — CEO, President
• Rahul Kushwah — COO
• Rakesh Malhotra — CFO, Company Secretary

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with P